Search research articles
Contact Us
Filters
Showing results (61-70 of 146) with videos related to
Page
of 15
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversity
Francesco Maura, David G Coffey, Caleb K Stein, et al.
Nature Communications
|
May 7, 2024
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans
Francesco Maura, David G Coffey, Caleb K Stein, et al.
Nature Communications
|
August 28, 2021
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
Kylee H Maclachlan, Even H Rustad, Andriy Derkach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2021
Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma
Bachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, et al.
American Journal of Hematology
|
March 2, 2013
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia
Carlo Visco, Francesca Moretta, Erika Falisi, et al.
Blood Cancer Journal
|
November 10, 2020
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features
Kimon V Argyropoulos, Melissa Pulitzer, Francesco Maura, et al.
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy
Paola Manara, Austin D Newsam, Venu Vg Saralamma, et al.
Haematologica
|
October 15, 2020
<i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
Francesco Maura, Anna Dodero, Cristiana Carniti, et al.
Seminars in Cell & Developmental Biology
|
May 7, 2021
Chromothripsis as a pathogenic driver of multiple myeloma
Francesco Maura, Eileen M Boyle, Even H Rustad, et al.
Leukemia Research
|
June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment
Fortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 146) with videos related to
Sort By:
Page
of 15
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversity
Francesco Maura, David G Coffey, Caleb K Stein, et al.
Nature Communications
|
May 7, 2024
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans
Francesco Maura, David G Coffey, Caleb K Stein, et al.
Nature Communications
|
August 28, 2021
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
Kylee H Maclachlan, Even H Rustad, Andriy Derkach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2021
Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma
Bachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, et al.
American Journal of Hematology
|
March 2, 2013
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia
Carlo Visco, Francesca Moretta, Erika Falisi, et al.
Blood Cancer Journal
|
November 10, 2020
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features
Kimon V Argyropoulos, Melissa Pulitzer, Francesco Maura, et al.
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy
Paola Manara, Austin D Newsam, Venu Vg Saralamma, et al.
Haematologica
|
October 15, 2020
<i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
Francesco Maura, Anna Dodero, Cristiana Carniti, et al.
Seminars in Cell & Developmental Biology
|
May 7, 2021
Chromothripsis as a pathogenic driver of multiple myeloma
Francesco Maura, Eileen M Boyle, Even H Rustad, et al.
Leukemia Research
|
June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment
Fortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
Page
of 15